|
Cancer type
|
GMD
|
Positive correlations
|
Negative correlations
|
|---|
|
GMD correlations with ≥ 5 individual probes
|
|
NSCLC
|
MGMT
|
25
|
0
|
|
CLLE
|
UHRF1
|
15
|
0
|
|
NSCLC
|
DNMT3A
|
12
|
0
|
|
NSCLC
|
PHC2
|
2
|
9
|
|
NSCLC
|
CBX2
|
8
|
2
|
|
BREAST
|
EHMT1
|
6
|
0
|
|
THCA
|
CBX2
|
6
|
0
|
|
CLLE
|
SUV39H2
|
5
|
0
|
|
COAD/READ
|
APOBEC1
|
0
|
34
|
|
CLLE
|
ZBTB38
|
0
|
25
|
|
BREAST
|
SMUG1
|
2
|
5
|
|
NSCLC
|
SETDB1
|
0
|
7
|
|
GMD correlations with > 100 gene regions
|
|
CLLE
|
UHRF1
|
1320
|
2
|
|
CLLE
|
CBX2
|
687
|
0
|
|
CLLE
|
PHC2
|
651
|
0
|
|
CLLE
|
CSNK1E
|
536
|
0
|
|
CLLE
|
EHMT2
|
392
|
0
|
|
COAD/READ
|
SIRT1
|
359
|
0
|
|
BREAST
|
EHMT1
|
268
|
39
|
|
CLLE
|
SUV39H2
|
293
|
1
|
|
SCLC
|
DNMT1
|
261
|
1
|
|
STAD
|
TET1
|
239
|
0
|
|
CLLE
|
IDH2
|
165
|
0
|
|
CLLE
|
DNMT1
|
154
|
0
|
|
SARCOMA
|
IDH2
|
139
|
5
|
|
STAD
|
CBX1
|
135
|
1
|
|
COAD/READ
|
SUZ12
|
126
|
1
|
|
CLLE
|
DNMT3B
|
120
|
0
|
|
GLIOMA
|
TET3
|
113
|
0
|
|
COAD/READ
|
UHRF1
|
111
|
0
|
|
CLLE
|
EZH2
|
106
|
0
|
|
BREAST
|
BCAT1
|
89
|
63
|
|
CLLE
|
ZBTB38
|
0
|
869
|
|
COAD/READ
|
APOBEC1
|
5
|
766
|
|
BREAST
|
SMUG1
|
34
|
273
|
|
BREAST
|
TDG
|
50
|
195
|
|
BREAST
|
APOBEC3C
|
22
|
97
|
- Listed are the counts of correlations satisfying p < 6.039 × 10–10 and Spearman |ρ| > 0.5 for individual probes and pFDR < 0.05 and Spearman |ρ| > 0.5 for gene regions
